About
Bioactive Lipid Technology
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (1)
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
417
By Phase
PHASE2: 5
By Status
TERMINATED: 2COMPLETED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05861453Lead Sponsor
Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease
PHASE2Active, not recruiting
30 participants
Started: Jan 10, 2024 · Completed: Mar 31, 2026
NCT04365400Lead Sponsor
Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes
PHASE2Terminated
233 participants
Started: Oct 13, 2020 · Completed: May 3, 2022
NCT03452540Lead Sponsor
Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic Hepatitis
PHASE2Terminated
9 participants
Started: Nov 28, 2018 · Completed: Mar 31, 2020
NCT03414541Lead Sponsor
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
PHASE2Completed
49 participants
Started: Sep 24, 2017 · Completed: Jan 29, 2019
NCT02941549Lead Sponsor
Safety And Efficacy Study Of Orally Administered Epeleuton In Patients With NAFLD
PHASE2Completed
96 participants
Started: Dec 20, 2016 · Completed: Mar 4, 2019
Locations (1)
Headquarters
Dublin, Ireland
Map
Loading map...